[1]
Ergasheva Gulshan Tokhirovna, “BREAKTHROUGH THERAPIES IN TYPE 2 DIABETES: ADVANCED ROLE OF GLP-1 RECEPTOR AGONISTS AND SGLT2 INHIBITORS”, imjrd, vol. 13, no. 4, pp. 882–885, Apr. 2026.